Skip to main content

Agonist Interaction with α 2-Adrenoceptors of Human Platelets

  • Conference paper
New Aspects in Hypertension Adrenoceptors
  • 50 Accesses

Abstract

The development of radioligand binding technique during the past decade has led to increased understanding of the cascade of events in hormone-receptor coupling and receptor-mediated signal-transducing processes [14].

This work was supported by a grant from the Deutsche Forschungsgemeinschaft. We are indebted to the Robert-Pfleger-Stiftung for generous gift of the Packard Tri-Carb and the Hewlett-Packard computer and to the Paul- and Cilli-Weill-Stiftung for the filtration device.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brodde OE, Engel G, Hoyer D, Bock KD, Weber F (1981) The β-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radioligand, (±)-125Iodocyanopindolol. Life Sci 29: 2189–2198

    Article  PubMed  CAS  Google Scholar 

  2. Brodde OE, Anlauf M, Graben N, Bock KD (1982 a) In vitro and in vivo down-regulation of human platelet α2-adrenoceptors by clonidine. Eur J Clin Pharmacol 23: 403–409

    Google Scholar 

  3. Brodde OE, Anlauf M, Graben N, Bock KD (1982b) Age-dependent decrease of a2-adrenergic receptor number in human platelets. Eur J Pharmacol 81: 345–347

    Article  PubMed  CAS  Google Scholar 

  4. Bylund DB, U’Prichard DC (1983) Characterization of alpha-1 and alpha-2 adrenergic receptors. Int Rev Neurobiol 24: 343–431

    Article  PubMed  CAS  Google Scholar 

  5. Cambridge D (1981) UK-14,304, a potent and selective a 2-agonist for the characterisation of α -adrenoceptor subtypes. Eur J Pharmacol 72: 413–415

    Article  PubMed  CAS  Google Scholar 

  6. Daiguji M, Meltzer HY, Tong C, U’Prichard DC, Young M, Kravitz H (1981) a2-Adrenergic receptors in platelet membranes of depressed patients: no change in number or 3H-yohimbine affinity. Life Sci 29: 2059–2064

    Google Scholar 

  7. Feldman HA (1972) Mathematical theory of complex ligand-binding systems at equilibrium. Some methods for parameter fitting. Anal Biochem 48: 317–338

    Article  PubMed  CAS  Google Scholar 

  8. Galant SP, Underwood S, Duriseti L, Insel PA (1978) Characterization of high-affinity β2-adrenergic receptor binding of (-)-dihydroalprenolol to human polymorphonuclear cell particulates. J Lab Clin Med 92: 613–618

    PubMed  CAS  Google Scholar 

  9. Grant J A, Scrutton MC (1980) Interaction of selective α-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol 71: 121–134

    PubMed  CAS  Google Scholar 

  10. Heidenreich KA, Weiland GA, Molinoff PB (1982) Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to β-adrenergic receptors. J Biol Chem 257: 804–810

    PubMed  CAS  Google Scholar 

  11. Hoffman BB, Michel T, Kilpatrick DM, Lefkowitz RJ, Tolbert MEM, Gilman H, Fain JN (1980) Agonist versus antagonist binding to α-adrenergic receptors. Proc Natl Acad Sci USA 77: 4569–4573

    Article  PubMed  CAS  Google Scholar 

  12. Hollister AS, Fitzgerald GA, Nadeau JH, Robertson D (1983) Acute reduction in human platelet α2-adrenoceptor affinity for agonist by endogenous and exogenous catecholamines. J Clin Invest 72: 1498–1505

    Article  PubMed  CAS  Google Scholar 

  13. Jakobs KH, Aktories H, Schultz G (1981) Inhibition of adenylate cyclase by hormones and neu-rotransmitters. Adv Cyclic Nucleotide Res 14: 173–187

    PubMed  CAS  Google Scholar 

  14. Lamble JW, Abbott AC (eds) (1984) Receptors, again. Elsevier, Amsterdam

    Google Scholar 

  15. Loftus DJ, Stolk JM, U’Prichard DC (1984) Binding of the imidazoline UK-14,304, a putative full α2-adrenoceptor agonist, to rat cerebral cortex membranes. Life Sci 35: 61–69

    Article  PubMed  CAS  Google Scholar 

  16. Lynch CJ, Steer ML (1981) Evidence for high and low affinity α2-receptors - Comparison of (3H)norepinephrine and (3H)phentolamine binding to human platelet membranes. J Biol Chem 256: 3298–3303

    PubMed  CAS  Google Scholar 

  17. Motulsky HJ, Insel PA (1982) Adrenergic receptors in man - Direct identification, physiologic regulation, and clinical alterations. N Engl J Med 307: 18–29

    Article  PubMed  CAS  Google Scholar 

  18. Motulsky HJ, Shattil SD, Insel PA (1980) Characterisation of α2-adrenergic receptors on human platelets using (3H)yohimbine. Biochem Biophys Res Commun 97: 1562–1570

    Article  PubMed  CAS  Google Scholar 

  19. Motulsky HJ, O’Connor DT, Insel PA (1983) Platelet α2-adrenergic receptors in treated and untreated essential hypertension. Clin Sci 64: 265–272

    PubMed  CAS  Google Scholar 

  20. Newman KD, Williams LT, Bishopric NH, Lefkowitz RJ (1978) Identification of α-adrenergic receptors in human platelets by (3H)dihydroergocryptine binding. J Clin Invest 61: 395–402

    Article  PubMed  CAS  Google Scholar 

  21. Perry BD, U’Prichard DC (1981) (3H)Rauwolscine (α-yohimbine): a specific antagonist radioligand for brain α2-adrenergic receptors. Eur J Pharmacol 76: 461–464

    Google Scholar 

  22. Pfeifer MA, Ward K, Malpass T, Stratton J, Halter J, Evans M, Beiter H, Harker LA, Porte D Jr (1984) Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for (3H)yohimbine or (3H)dihydroergocryptine. J Clin Invest 74: 1063–1072

    Article  PubMed  CAS  Google Scholar 

  23. Reinhardt D, Becker B, Nagel-Hiemke M, Schiffer R, Zehmisch T (1983) Influence of beta- receptor-agonists and glucocorticoids on alpha- and beta-adrenoceptors of isolated blood cells from asthmatic children. Pediatr Pharmacol (New York) 3: 293–302

    CAS  Google Scholar 

  24. Schloos J, Vogt C, Palm D (1985) Agonist-induced high-affinity state of α2-adrenoceptors of human platelets characterized by 3H-antagonist and 3H-agonist binding. Naunyn Schmiedebergs Arch Pharmacol 330 [Suppl]: R61

    Google Scholar 

  25. Smith SK, Limbird LE (1981) Solubilization of human platelet α-adrenergic receptors: Evidence that agonist occupancy of the receptor stabilizes receptor-effector interactions. Proc Natl Acad Sci USA 7: 4026–4030

    Google Scholar 

  26. Starke K (1981) α-Adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88: 199-236

    Google Scholar 

  27. Sundaresan PR, Madan MK, Kelvie SL, Weintraub M (1985) Platelet alpha-2 adrenoceptors and the menstrual cycle. Clin Pharmacol Ther 37: 337–342

    Article  PubMed  CAS  Google Scholar 

  28. Tsai BS, Lefkowitz RJ (1979) Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets. Mol Pharmacol 16: 61–68

    PubMed  CAS  Google Scholar 

  29. U’Prichard DC, Snyder SH (1978 a) Guanyl nucleotide influences on 3H-ligand binding at α-noradrenergic receptors in calf brain membranes. J Biol Chem 253: 3444–3452

    Google Scholar 

  30. U’Prichard DC, Snyder SH (1978b) 3H-Catecholamine binding to α-receptors in rat brain: En-hancement by reserpine. Eur J Pharmacol 51: 145–155

    Google Scholar 

  31. van Meel JCA, de Jonge A, Timmermans PBMWM, van Zwieten PA (1981) Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normoten- sive rat. J Pharmacol Exp Ther 219: 760–767

    Google Scholar 

  32. Wellstein A, Palm D (1984) Theory of ligand-receptor interactions - Evidence for more than one site. In: Erdmann E (ed) Cardiac glycoside receptors and positive inotropy. Steinkopff, Darmstadt, pp 9–15

    Google Scholar 

  33. Wiemer G, Wellstein A, Palm D, von Hattingberg HM, Brockmeier D (1982) Properties of agonist binding at the β-adrenoceptor of the rat reticulocyte. Naunyn-Schmiedebergs Arch Pharmacol 321: 11–19

    Article  PubMed  CAS  Google Scholar 

  34. Wikberg JES (1979) The pharmacological classification of adrenergic α1 and α2 receptors and their mechanism of action. Acta Physiol Scand [Suppl] 468: 5–99

    Google Scholar 

  35. Yamamura HI, Enna SJ, Kuhar MJ (1978) Neurotransmitter receptor binding. Raven, New York

    Google Scholar 

  36. Yokoyama M, Kusui A, Sakamoto S, Fukuzaki H (1984) Age-associated increments in human platelet α-adrenoceptor capacity - Possible mechanism for platelet hyperactivity to epinephrine in aging man. Thromb Res 34: 287–295

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schloos, J., Palm, D. (1986). Agonist Interaction with α 2-Adrenoceptors of Human Platelets. In: Middeke, M., Holzgreve, H. (eds) New Aspects in Hypertension Adrenoceptors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71418-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71418-4_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71420-7

  • Online ISBN: 978-3-642-71418-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics